GLP‑1 and menstrual changes: what the evidence says

Introduction

You may notice changes in menstrual timing or flow while losing weight or taking a GLP‑1 medicine such as semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound). Researchers have limited evidence about cycle changes during GLP‑1 treatment, so a change does not prove the medicine caused it. This article covers polycystic ovary syndrome (PCOS), contraception, pregnancy planning, and when to seek care.

What research says about menstrual changes

Small studies in people with PCOS suggest GLP‑1 medicines may improve menstrual regularity as weight and metabolic health change. 1 The evidence does not show that these medicines cause a predictable pattern of heavier, longer, or irregular periods in everyone. Weight change, PCOS, pregnancy, stress, and other health conditions can affect cycles.

If your cycle changes, record dates, bleeding, symptoms, dose changes, and pregnancy tests if relevant. Share that timeline with your clinician and let them assess causes beyond medication.

Tirzepatide can affect oral contraceptive reliability

Tirzepatide slows stomach emptying and may reduce the effectiveness of oral hormonal birth control during treatment initiation and dose increases. The U.S. prescribing information advises using a non-oral hormonal method or adding a barrier method for four weeks after starting tirzepatide and for four weeks after each dose increase. 3 4 The label does not warn that tirzepatide affects non-oral hormonal contraceptives.

This warning applies to tirzepatide products such as Mounjaro and Zepbound. Ask your prescriber or pharmacist how your specific medication may affect oral medicines.

Plan pregnancy with your prescriber

Semaglutide product labeling says to stop at least two months before a planned pregnancy. 5 6 U.S. tirzepatide labeling says to discontinue when pregnancy is recognized; the UK medicines regulator advises stopping tirzepatide at least one month before a planned pregnancy. 3 7 Ask your prescriber for a plan before trying to conceive, since the instructions depend on the product and the reason you take it.

If you become pregnant while taking a GLP‑1 medicine, contact your prescriber for instructions. Do not continue treatment without medical guidance.

When to contact a clinician

Contact your OB-GYN or prescriber about a new or persistent cycle change, bleeding between periods, bleeding after sex, or a missed period when pregnancy is possible. Contact a clinician if you soak through a pad or tampon every hour for 2 to 3 hours, if bleeding lasts longer than a week, or if bleeding causes weakness or lightheadedness. Seek urgent care for fainting or severe bleeding. 2

Track cycle changes with Shotsy

Use Shotsy notes to record cycle dates, bleeding, symptoms, and medication timing. A timeline can help you explain what changed to your clinician, but it cannot identify the cause.

Conclusion

Cycle changes can have several causes, and current evidence does not establish a predictable menstrual effect for GLP‑1 medicines. Tirzepatide has a specific warning for oral contraceptives, and semaglutide and tirzepatide have different pregnancy instructions. Review any change with your clinician and plan pregnancy before treatment changes.